Public bioethics advisory bodies have been a staple of US public policy for addressing public biotechnology- related controversies, in spite of the limited impact these bodies have had on policy-making. These advisory bodies serve an important tacit function as boundary organizations that stabilize the border between science and politics, preserving the autonomy of science from incursion by other societal stakeholders. In this paper the boundary work of the US National Bioethics Advisory Commission is examined at the border of science and ethics, in its deliberations on embryonic stem cell research. The coupling of scientific and ethical uncertainty, and that of research productivity and integrity assurance in the Commission's deliberations is described. It is argued that the Commission's boundary work reinforced the authority of science and marginalized conflicting civic-sector concerns.
No takes yet. Share an insight, caveat, or question.
Mary Leinhos (2005) studied this question.